The Worldwide AI in Healthcare Industry is Expected to Reach $208.2 Billion by 2030

DUBLIN, July 20, 2022 /PRNewswire/ -- The "Artificial Intelligence In Healthcare Market Size, Share, and Trends Analysis Report by Component (Software Solutions, Hardware, Services), by Application (Virtual Assistants, Connected Machines), by Region, and Segment Forecasts, 2022-2030" report has been added to ResearchAndMarkets.com's offering.

The global artificial intelligence in healthcare market size is expected to reach USD 208.2 billion by 2030. The market is expected to expand at a CAGR of 38.4% from 2022 to 2030.

The growing demand for personalized medicine, rising demand for value-based care, growing datasets of patient health-related digital information, advancements in healthcare IT infrastructure, penetration of smartphones, improved internet connectivity, and shortage of care providers is propelling the growth of the market over the forthcoming years.

In addition, changing lifestyles, the growing geriatric population, rising prevalence of chronic diseases have contributed to the need for faster and accurate disease detection and improving the understanding of the disease in the early stage, thereby driving the adoption of technologies based on Artificial Intelligence (AI) in healthcare. The ongoing Covid-19 pandemic positively impacted the adoption of AI-based technologies and unearthed the potential they withhold. Healthcare systems began adopting AI-based technologies in faster and early diagnosis & detection of diseases and quicker & accurate clinical trials.

Furthermore, AI-based technologies were implemented in virtual assistants, robot-assisted surgeries, claims management, cybersecurity, and patient management. AI algorithms were trained with patient health datasets to optimize the diagnosis and detection of diseases at an early stage, to begin with, an optimum treatment regime. Supportive government initiatives, a growing number of investments from private investors and venture capitalists, and the emergence of AI-specialized startups across the globe are driving the market growth. Software solutions dominated in 2021, owing to the rapidly rising adoption rates of software solutions in healthcare systems and the growing penetration of these technologies in various applications.

The clinical trials segment dominated in 2021, owing to the adoption of these technologies in clinical trial designing, study adherence, patient recruitment, and minimized patient dropout. North America region dominated in 2021, owing to the availability of optimum IT infrastructure, technological literacy, presence of key players & local developers, and lucrative funding options. Key players are focusing on devising innovative product development strategies through mergers & acquisitions and collaborations to expand their product portfolio and cater to larger business geographies.

Artificial Intelligence In Healthcare Market Report Highlights

• The AI in healthcare market size is anticipated to be valued at USD 208.2 billion by 2030, owing to the growing datasets of patient health-related information, advancing healthcare IT infrastructure, and growing need for accurate and early disease diagnosis
• The software solutions segment dominated the global market in 2021, due to the widespread adoption of AI-based software solutions amongst care providers, payers, and patients.
• The clinical trials segment dominated the market in 2021, owing to the growing demand for faster and accurate clinical trials with enhanced accuracy and reliability
• North America dominated in 2021, owing to advancements in healthcare IT infrastructure, readiness to adopt advanced technologies, presence of several key players, growing geriatric population, and rising prevalence of chronic diseases

Key Topics Covered:

Chapter 1 Research Methodology & Scope

Chapter 2 Executive Summary

Chapter 3 Global Artificial Intelligence In Healthcare Market Variables, Trends, & Scope
3.1 Artificial Intelligence In Healthcare Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Related/ancillary market outlook
3.2 Penetration and Growth Prospect Mapping
3.3 User Perspective Analysis
3.3.1 Consumer behavior analysis
3.3.2 Market influencer analysis
3.4 List of Key End-users
3.5 Technology Overview
3.6 Regulatory Framework
3.7 Market Dynamics
3.7.1 Market Driver Analysis
3.7.2 Market Restraint Analysis
3.7.3 Industry Challenges
3.8 Global Artificial Intelligence In Healthcare Market Analysis Tools
3.8.1 Industry Analysis-Porter's
3.8.1.1 Bargaining power of the suppliers
3.8.1.2 Bargaining power of the buyers
3.8.1.3 Threats of substitution
3.8.1.4 Threats from new entrants
3.8.1.5 Competitive rivalry
3.8.2 PESTEL Analysis
3.8.2.1 Political landscape
3.8.2.2 Economic and Social landscape
3.8.2.3 Technology landscape
3.8.2.4 Legal landscape
3.8.2.5 Technology landscape
3.9 Major Deals & Strategic Alliances Analysis
3.9.1 Joint Ventures
3.9.2 Mergers & Acquisitions
3.9.3 Licensing & Partnership
3.9.4 Technology Collaborations
3.10 Impact of COVID-19 Pandemic on Artificial Intelligence In Healthcare Market

Chapter 4 Artificial Intelligence In Healthcare Market: Component Estimates & Trend Analysis
4.1 Definitions & Scope
4.2 Market: Component Market Share Analysis, 2021 and 2030
4.3 Software solutions
4.3.1 Market estimates and forecasts, 2016-2030 (USD Million)
4.4 Hardware
4.4.1 Market estimates and forecasts, 2016-2030 (USD Million)
4.5 Services
4.5.1 Market estimates and forecasts, 2016-2030 (USD Million)

Chapter 5 Artificial Intelligence In Healthcare Market: Application Estimates & Trend Analysis
5.1 Definitions & Scope
5.2 Market: Application Market Share Analysis, 2021 and 2030
5.3 Robot assisted surgery
5.3.1 Market estimates and forecasts, 2016-2030 (USD Million)
5.4 Virtual assistants
5.4.1 Market estimates and forecasts, 2016-2030 (USD Million)
5.5 Administrative workflow assistants
5.5.1 Market estimates and forecasts, 2016-2030 (USD Million)
5.6 Connected machines
5.6.1 Market estimates and forecasts, 2016-2030 (USD Million)
5.7 Diagnosis
5.7.1 Market estimates and forecasts, 2016-2030 (USD Million)
5.8 Clinical trials
5.8.1 Market estimates and forecasts, 2016-2030 (USD Million)
5.9 Fraud detection
5.9.1 Market estimates and forecasts, 2016-2030 (USD Million)
5.10 Cybersecurity
5.10.1 Market estimates and forecasts, 2016-2030 (USD Million)
5.11 Dosage error reduction
5.11.1 Market estimates and forecasts, 2016-2030 (USD Million)

Chapter 6 Artificial Intelligence In Healthcare Market: Regional Estimates & Trend Analysis, By Component, and Application

Chapter 7 Competitive Analysis
7.1 Recent Developments & Impact Analysis, By Key Market Participants
7.2 Company/Competition Categorization (Key innovators, Market leaders, Emerging Players)
7.3 Vendor Landscape
7.3.1 Key Company Market Share Analysis, 2021
7.3.2 List of key distributors and channel partners
7.4 Public Companies
7.4.1 Company Market Position Analysis (Geographic Presence, Product Portfolio, Key Alliance, Industry Experience)
7.5 Private Companies
7.5.1 List of Key Emerging Companies /Technology Disruptors/Innovators
7.5.2 Company Market Position Analysis (Geographic Presence, Product Portfolio, Key Alliance, Industry Experience)

Chapter 8 Artificial Intelligence In Healthcare Market: Technology Qualitative Trend & Dynamic Analysis
8.1 Qualitative Trend & Dynamic Analysis
8.1.1 Machine Learning
8.1.2 Natural Language Processing
8.1.3 Computer Vision
8.1.4 Context Aware Processing

Chapter 9 Company Profiles
9.1 IBM Corporation
9.1.1 Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.2 Microsoft
9.2.1 Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.3 Intel Corporation
9.3.1 Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.4 NVIDIA Corporation
9.4.1 Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.5 Nuance Communications, Inc.
9.5.1 Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.6 DeepMind Technologies Limited
9.6.1 Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.7 List of Other Players

For more information about this report visit https://www.researchandmarkets.com/r/6epy8s

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets